# Stillwater&#8217;s Lift Bridge Brewery Faces $1.8M THC Beverage Dispute

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/hemp-derived-thc-beverage-regulation-dispute/
> **Published:** 2026-04-01T20:03:23-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:10:31-04:00
> **Clinical Summary:** Explore hemp-derived THC beverage regulation and the $1.8M legal dispute involving Lift Bridge Brewery highlighting product safety and quality control issues.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
[Hemp-Derived Thc](https://cedclinic.com/hemp-derived-thc-products-regulation-patient-access/)Product SafetyRegulationBeveragesQuality Control

Why This Matters

Commercial disputes over THC beverage production highlight the unregulated nature of hemp-derived delta-9 THC products entering the market. This regulatory gap creates unpredictable dosing and quality control issues that directly impact patient safety and clinical outcomes.

Clinical Summary
A $1.8 million legal dispute between Stillwater’s Lift Bridge Brewery and a THC beverage partner underscores the complex business and regulatory landscape surrounding hemp-derived cannabis drinks. These products exploit federal hemp legislation loopholes to deliver psychoactive THC doses while avoiding traditional cannabis regulations. The legal complexity reflects broader industry challenges with quality control, standardization, and regulatory oversight that affect product consistency and safety.

Dr. Caplan’s Take

“I see patients regularly confused by these unregulated THC drinks appearing in gas stations and breweries — they assume FDA oversight exists when it doesn’t. The business disputes are less important than the regulatory vacuum leaving consumers without safety guarantees.”

Clinical Perspective
🧠 Clinicians should advise patients that [hemp-derived THC](https://cedclinic.com/hemp-derived-thc-products-regulation-patient-access/) beverages lack the testing, labeling, and quality standards of regulated cannabis products. Patients using these products may experience unpredictable effects due to inconsistent dosing. Until proper regulatory frameworks emerge, [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) programs remain the most reliable source for standardized THC products.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Stillwater%27s%20Lift%20Bridge%20Brewery%20owes%20%241.8M%20in%20THC%20drink%20dispute%20-%20Star%20Tribune%20%40drcaplan&url=https%3A//www.startribune.com/lift-bridge-brewery-lawsuit-lyvly-thc-seltzer-hemp-derived-cannabis-drink-fiduciary-duty-fraud/601651717)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.startribune.com/lift-bridge-brewery-lawsuit-lyvly-thc-seltzer-hemp-derived-cannabis-drink-fiduciary-duty-fraud/601651717)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Stillwater%27s%20Lift%20Bridge%20Brewery%20owes%20%241.8M%20in%20THC%20drink%20dispute%20-%20Star%20Tribune%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.startribune.com/lift-bridge-brewery-lawsuit-lyvly-thc-seltzer-hemp-derived-cannabis-drink-fiduciary-duty-fraud/601651717)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://www.startribune.com/lift-bridge-brewery-lawsuit-lyvly-thc-seltzer-hemp-derived-cannabis-drink-fiduciary-duty-fraud/601651717](https://www.startribune.com/lift-bridge-brewery-lawsuit-lyvly-thc-seltzer-hemp-derived-cannabis-drink-fiduciary-duty-fraud/601651717)

Table of Contents

- [FAQ](#FAQ)[What are hemp-derived THC products?](#What_are_hemp-derived_THC_products)
- [Are hemp-derived THC beverages safe to consume?](#Are_hemp-derived_THC_beverages_safe_to_consume)
- [How are hemp-derived THC products regulated?](#How_are_hemp-derived_THC_products_regulated)
- [What should clinicians know about patients using hemp-derived THC beverages?](#What_should_clinicians_know_about_patients_using_hemp-derived_THC_beverages)
- [Why is this topic considered clinically relevant?](#Why_is_this_topic_considered_clinically_relevant)
- [Related](#Related)

## FAQ

#### What are hemp-derived THC products?

Hemp-derived THC products are cannabis products that contain THC extracted from hemp plants rather than marijuana plants. These products must contain less than 0.3% Delta-9 THC by dry weight to comply with federal hemp regulations under the [2018 Farm Bill](https://cedclinic.com/south-carolina-hemp-regulations-thc-edibles-policy-options/).

#### Are hemp-derived THC beverages safe to consume?

The safety of hemp-derived THC beverages depends on proper manufacturing, testing, and quality control measures. Consumers should look for products that have been third-party tested and follow proper dosing guidelines to avoid adverse effects.

#### How are hemp-derived THC products regulated?

Hemp-derived THC products exist in a complex regulatory environment with oversight from multiple agencies including the FDA, DEA, and state regulators. Regulations vary significantly by state, with some allowing these products while others have banned or restricted them.

#### What should clinicians know about patients using hemp-derived THC beverages?

Clinicians should be aware that these products can cause psychoactive effects and may interact with medications. It’s important to screen patients for use and provide guidance on potential risks, especially regarding dosing and product quality variations.

#### Why is this topic considered clinically relevant?

This topic has notable clinical interest due to emerging findings about product safety and evolving policy developments. Healthcare providers need to stay informed as the regulatory landscape changes and more patients may be using these readily available products.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Stillwater’s Lift Bridge Brewery owes $1.8M in THC drink dispute – Star Tribune”, “url”: “https://www.startribune.com/lift-bridge-brewery-lawsuit-lyvly-thc-seltzer-hemp-derived-cannabis-drink-fiduciary-duty-fraud/601651717”, “datePublished”: “2026-04-01T19:14:14Z”, “about”: “stillwater s lift bridge brewery owes”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Jury decides Lift Bridge should pay $1.8M in damages in cannabis beverage production case](https://cedclinic.com/cannabis-beverage-production-dispute-1-8m-damages/)

Detailed coverage of the jury decision against Lift Bridge Brewery in the $1.8 million cannabis beverage dispute.

[Read the full case details](https://cedclinic.com/cannabis-beverage-production-dispute-1-8m-damages/)

[Dr. Rand Paul Introduces the Bipartisan Hemp Safety Enforcement Act](https://cedclinic.com/hemp-safety-enforcement-act-federal-standards/)

Learn about new legislative efforts aimed at improving [hemp product safety](https://cedclinic.com/pediatric-cannabinoid-ingestions-preventable-overdose-risks/) and enforcement.

[Explore the hemp safety act](https://cedclinic.com/hemp-safety-enforcement-act-federal-standards/)

[Landmark Colorado Bill Introduced to Modernize Colorado THC Drinks Sales | Vicente LLP](https://cedclinic.com/colorado-thc-drinks-sales-legislation-modernizes/)

Insights into legislative modernization efforts for THC beverage sales in Colorado, relevant to hemp-derived products.

[Discover Colorado's THC beverage laws](https://cedclinic.com/colorado-thc-drinks-sales-legislation-modernizes/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
